De Fiesta, Marilou L.

HRN: 28-85-42  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/28/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/28/2026
04/29/2026
IV
1g
1 Dose Only. Prior To OR
Herniated Nucleus Pulposus L4L5
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bone & Joint    Compliance to guidelines: